Research Papers:

Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location

Lorena Brandariz, María Arriba, Juan Luis García, Juana María Cano, Daniel Rueda, Eduardo Rubio, Yolanda Rodríguez, Jessica Pérez, Alfredo Vivas, Carmen Sánchez, Sandra Tapial, Laura Pena, Mariano García-Arranz, Damián García-Olmo, Miguel Urioste, Rogelio González-Sarmiento and José Perea _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:15302-15311. https://doi.org/10.18632/oncotarget.24502

Metrics: PDF 1486 views  |   HTML 2393 views  |   ?  


Lorena Brandariz1, María Arriba2, Juan Luis García3,4, Juana María Cano5, Daniel Rueda6,7, Eduardo Rubio8, Yolanda Rodríguez9, Jessica Pérez3,4, Alfredo Vivas8, Carmen Sánchez8, Sandra Tapial7, Laura Pena10, Mariano García-Arranz11, Damián García-Olmo1,11, Miguel Urioste10,12, Rogelio González-Sarmiento3,4 and José Perea1,11

1Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain

2Biochemistry Department, Gregorio Marañón University Hospital, Madrid, Spain

3Molecular Medicine Unit, Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain

4Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-SACYL-CSIC, Salamanca, Spain

5Oncology Department, Ciudad Real General Hospital, Ciudad Real, Spain

6Molecular Biology Laboratory, “12 de Octubre” Universitary Hospital, Madrid, Spain

7Digestive Cancer Research Group, “12 de Octubre” Research Institute, Madrid, Spain

8Surgery Department, “12 de Octubre” Universitary Hospital, Madrid, Spain

9Pathology Department, “12 de Octubre” Universitary Hospital, Madrid, Spain

10Familial Cancer Clinical Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain

11Health Research Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain

12Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Correspondence to:

José Perea, email: [email protected]

Keywords: late-onset colorectal cancer; microsatellite instability; chromosomal instability; CpG island methylator phenotype; colon location

Received: November 27, 2017     Accepted: February 10, 2018     Epub: February 15, 2018     Published: March 16, 2018


Background: Since there is a predilection of some clinical and molecular features for a given tumor location, we assessed whether this can be confirmed in late-onset colorectal cancer (LOCRC).

Results: Right colon cancers showed features associated with sporadic Microsatellite Instability: predominance of female cases and BRAF mutations, and an important mucinous component. Left colon cancers developed a higher number of polyps and multiple primary CRCs, showed the strongest familial component, and had better prognosis. Rectal cancers showed a predominantly sporadic phenotype, with worse prognosis and a CpG Island Methylator Phenotype (CIMP)-High. No copy number alterations (CNAs) greater than or equal to 50% were observed in this LOCRC group, and the most recurrent alterations were losses at 5q13 and 14q11, and gains at 7q11, 7q21-q22, 19p13-p12, 19q13 and 20p11-q11. KRAS and PIK3CA were the only mutated genes showing differences according to the tumor location, mainly for right colon cancers.

Materials and Methods: We analyzed clinical and molecular characteristics of LOCRC at different tumor locations in order to determine if there are differential phenotypes related with the location in the colon.

Conclusions: Categorizing LOCRC according to tumor location appears to be an adequate first step to resolving the heterogeneity of this subset of CRC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24502